Payer & Health Plan Administration · Healthcare & Life Sciences
Should you build or buy Risk Adjustment Coding & HCC Capture Platform?
Risk Adjustment Coding & HCC Capture Platform software identifies Hierarchical Condition Category coding gaps in Medicare Advantage and ACA member populations, retrieves and abstracts clinical charts to support HCC capture, and manages the risk adjustment data submission workflow to optimize plan revenue under CMS's risk-adjusted payment model. It combines analytics for RAF gap identification with NLP-based chart abstraction and RADV audit defense.
The build-vs-buy decision for Risk Adjustment Coding & HCC Capture Platform turns on how far AI-native chart abstraction has moved the per-chart economics in favor of internal builds and how much a plan's specific member population and RAF strategy can be better served by a proprietary model than a vendor platform; the calculus is actively moving as LLM abstraction costs fall.
Build it, buy it, or bridge?
When building makes sense
The build case for HCC capture has shifted from theoretical to credible. NLP-based chart abstraction is in production at multiple large plans and in platforms like Apixio and Reveleer that essentially proved the methodology. The HCC model itself is CMS-standard, so the differentiation lives in how a plan prioritizes gaps, stratifies its risk cohort, and defends its coding under RADV audit, all of which reflect proprietary strategy rather than vendor defaults. What's changed in the last two years is the cost curve: LLM-based chart abstraction using models like Claude and GPT-4 costs a fraction of traditional per-chart vendor pricing at sufficient volume. Large plans that previously had no viable self-build path are re-evaluating because the per-chart economics increasingly favor an internal pipeline. The build case is strongest for plans with developed ML teams, sufficient member volume to train risk models on their own population, and a strategic view that RADV audit defense benefits from owning the abstraction methodology.
When buying makes sense
Buying makes sense when vendor abstraction capacity lets a plan scale chart review for the current plan year without building NLP infrastructure from scratch. Vendors like Apixio, Cotiviti, and Vatica Health have production-grade abstractors and established chart retrieval workflows that deliver results against current-year gaps faster than an internal build could. For plans without data science teams, the vendor model is the only practical path. Even for plans building internal capabilities, vendor platforms provide a volume buffer during the transition period when internal models are still being trained and validated. The plan-specific member population and coding strategy layer can be overlaid on vendor gap analytics through configuration, and the vendor's established CMS submission workflows reduce the compliance risk that comes with internal data handling under RADV scrutiny.
The desk read
HCC gap identification and chart abstraction for risk adjustment have become a credible build target. The underlying HCC model is CMS-standard, and NLP-based chart abstraction is in production at multiple large plans and in vendor platforms like Apixio and Reveleer. The methodology is proven. What differs between organizations is the membership population, risk cohort strategy, and RADV audit approach, and those differences can drive meaningful customization in how you prioritize gaps and manage abstractor workflows.
Buying earns its keep when vendor abstraction capacity lets you scale chart review without building internal NLP infrastructure. The build case gets serious when you're at a volume where per-chart vendor pricing exceeds what LLM-based abstraction pipelines cost internally, which is increasingly common as OpenAI and Claude API pricing continues to fall. AI has made this category live again: large plans that previously had no viable self-build path are now re-evaluating, and the economics favor internal builds at scale.
Frequently asked
What is Risk Adjustment Coding & HCC Capture Platform software?
Risk Adjustment Coding & HCC Capture Platform software identifies Hierarchical Condition Category coding gaps in Medicare Advantage and ACA member populations, retrieves and abstracts clinical charts to support HCC capture, and manages the risk adjustment data submission workflow to optimize plan revenue under CMS's risk-adjusted payment model. It combines analytics for RAF gap identification with NLP-based chart abstraction and RADV audit defense.
When does building Risk Adjustment Coding & HCC Capture Platform make sense?
Building is credible for large plans with ML teams and sufficient member volume, where LLM-based chart abstraction costs less per chart than vendor pricing and where owning the risk stratification and RADV audit methodology creates a genuine revenue advantage.
When does buying Risk Adjustment Coding & HCC Capture Platform make sense?
Buying makes sense for plans without NLP infrastructure, for current plan-year gap work where vendor throughput is faster than a new build, and as a capacity buffer while an internal abstraction pipeline is developed and validated.
What are the main Risk Adjustment Coding & HCC Capture Platform vendors?
Representative vendors include Apixio, Cotiviti, Vatica Health, Reveleer. B4 Pro scores the full set.
What is RADV and why does it matter for HCC capture strategy?
RADV (Risk Adjustment Data Validation) is CMS's audit process that validates the accuracy of HCC coding used to calculate risk-adjusted payments for Medicare Advantage plans. Plans with defensible chart documentation and abstraction methodology are better positioned in RADV audits, which is one reason owning the abstraction and coding workflow has growing strategic value.